The Common Good is a quarterly series hosted by the PCDC. We’re inviting thought leaders from across the fields of oncology, clinical trials, and international data sharing to talk about big ideas that can redefine how we think about cancer research and treatment. The more we learn from each other, the better we can all work toward the common good.
2020 Vision: The Future of Clinical Trials Is Here. Are We?
Wednesday, October 27, 2021
11:00am – 12:00pm Central Time
In this webinar Greg Simon, former President of the Biden Cancer Initiative, will describe the recent progress made in patient-friendly clinical trials and the need to retain these changes to increase diversity and equity and to lessen the burden on patients wherever possible. Having leapt ten years ahead due to Covid, let’s not go back to 2019.
Greg Simon is an expert analyst of emerging trends in healthcare, information technology, innovative drug research and development, and patient advocacy. Most recently, he was the President of the Biden Cancer Initiative. He previously served as the Executive Director of the White House Cancer Moonshot Task Force, where he and his team helped launch over seventy innovative collaborations. Greg returned to the White House after serving as Vice President Al Gore’s Chief Domestic Policy Advisor between 1993 and 1997. He has also served as Senior Vice President for Worldwide Policy and Patient Engagement at Pfizer; CEO of Poliwogg, a financial services company creating unique capital market opportunities in healthcare and life sciences; and a senior strategy consultant to a variety of international technology CEOs. He co-founded FasterCures/The Center for Accelerating Medical Solutions and the Melanoma Research Alliance. Greg is a cancer survivor, having been recently successfully treated for chronic lymphocytic leukemia.